PMID- 16159986 OWN - NLM STAT- MEDLINE DCOM- 20060508 LR - 20191210 IS - 1468-201X (Electronic) IS - 1355-6037 (Print) IS - 1355-6037 (Linking) VI - 92 IP - 4 DP - 2006 Apr TI - Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. PG - 490-4 AB - OBJECTIVE: To evaluate the impact of long term cardiac resynchronisation therapy (CRT) on left atrial and left ventricular (LV) reverse remodelling and reversal to sinus rhythm (SR) in patients with heart failure with atrial fibrillation (AF). PATIENTS: 74 consecutive patients (age 68 (8) years; 67 men) with advanced heart failure and AF (20 persistent and 54 permanent) were implanted with a CRT device. MAIN OUTCOME MEASURES: Patients were evaluated clinically (New York Heart Association (NYHA) class, quality of life, six minute walk test) and echocardiographically (LV ejection fraction, LV diameters, and left atrial diameters) before and after six months of CRT. Additionally, restoration of SR was evaluated after six months of CRT. RESULTS: NYHA class, quality of life score, six minute walk test, and LV ejection fraction had improved significantly after six months of CRT. In addition, left atrial and LV end diastolic and end systolic diameters had decreased from 59 (9) to 55 (9) mm, from 72 (10) to 67 (10) mm, and from 61 (11) to 56 (11) mm, respectively (all p < 0.01). During implantation 18 of 20 (90%) patients with persistent AF were cardioverted to SR. At follow up 13 of 18 (72%) patients had returned to AF and none had spontaneously reverted to SR; thus, only 5 of 74 (7%) were in SR. CONCLUSION: Six months of CRT resulted in significant clinical benefit with significant left atrial and LV reverse remodelling. Despite these beneficial effects, 93% of patients had not reverted to SR. FAU - Kies, P AU - Kies P AD - Department of Cardiology, Leiden University Medical Centre, The Netherlands. FAU - Leclercq, C AU - Leclercq C FAU - Bleeker, G B AU - Bleeker GB FAU - Crocq, C AU - Crocq C FAU - Molhoek, S G AU - Molhoek SG FAU - Poulain, C AU - Poulain C FAU - van Erven, L AU - van Erven L FAU - Bootsma, M AU - Bootsma M FAU - Zeppenfeld, K AU - Zeppenfeld K FAU - van der Wall, E E AU - van der Wall EE FAU - Daubert, J-C AU - Daubert JC FAU - Schalij, M J AU - Schalij MJ FAU - Bax, J J AU - Bax JJ LA - eng PT - Evaluation Study PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20050913 PL - England TA - Heart JT - Heart (British Cardiac Society) JID - 9602087 SB - IM MH - Aged MH - Atrial Fibrillation/diagnostic imaging/etiology/*therapy MH - Cardiac Pacing, Artificial/*methods MH - Exercise Test MH - Female MH - Heart Atria/diagnostic imaging/pathology MH - Heart Failure/complications/diagnostic imaging/*therapy MH - Humans MH - Male MH - Middle Aged MH - Pacemaker, Artificial MH - Quality of Life MH - Treatment Outcome MH - Ultrasonography PMC - PMC1860874 COIS- Competing interests: none declared EDAT- 2005/09/15 09:00 MHDA- 2006/05/09 09:00 PMCR- 2009/04/01 CRDT- 2005/09/15 09:00 PHST- 2005/09/15 09:00 [pubmed] PHST- 2006/05/09 09:00 [medline] PHST- 2005/09/15 09:00 [entrez] PHST- 2009/04/01 00:00 [pmc-release] AID - hrt.2005.064816 [pii] AID - ht64816 [pii] AID - 10.1136/hrt.2005.064816 [doi] PST - ppublish SO - Heart. 2006 Apr;92(4):490-4. doi: 10.1136/hrt.2005.064816. Epub 2005 Sep 13.